MEDIAN Technologies (ALMDT), the leading provider of clinical applications for quantitative management of treatment response in oncology imaging, today announced that it is a coauthor on a poster to be presented at the 2011 Annual Congress of the American Society of Clinical Oncology (ASCO), to be held June 3-7 at the McCormick Place venue in Chicago, IL.
Together with researchers at the University of Minnesota, MEDIAN Technologies has written a poster entitled “Computer-aided volumetry analysis in assessing pulmonary chemotherapy response in advanced NSCLC comparing with RECIST criteria”. The poster (#10593) will be presented between 8 am and noon on June 6, during the “Tumor Biology” session in Hall A.
For more information on the poster, visit: http://abstract.asco.org/AbstView_102_83027.html
“The ASCO annual meeting is an event that experts in this field cannot afford to miss and we are particularly pleased that the University of Minnesota researchers will be presenting this poster”, commented MEDIAN Technologies’ Chairman and CEO Fredrik Brag. “This is an especially strategic presentation because the research is a perfect illustration of our CTIS solution for performing clinical trials in oncology, which will be presented at the ASCO meeting for the first time this year”, he added.
The authors are: L. Ding, R. L. Bliss, M. Ingebrand, T. Allen, P. Ives, A. Dudek, R. A. Kratzke; University of Minnesota, Minneapolis, MN; MEDIAN Technologies Inc., Minneapolis, MN; Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN.